SOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the SOPHiA GENETICS Q1 2025 Earnings Call. [Operator Instructions]. This call is being recorded on Tuesday, May 6, 2025.
Sophia Genetics Sa (SOPH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Akre Capital Management Charles Akre | 2,237,504 | $7,428,513 | 0.07% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,211,040 | $7,340,653 | 0.06% | |
| 2. | 1,409,160 | $4,678,411 | 2.15% | |
| 3. | 1,385,013 | $4,598,243 | 0% | |
| 4. | 255,200 | $847,264 | 0.02% | |
| 5. | 189,000 | $627,480 | 0% |
News See All
SOPHiA GENETICS SA (NASDAQ:SOPH) Q4 2024 Earnings Call Transcript
Operator: Good morning. My name is Liway, and I'll be your conference operator today.
SOPHiA GENETICS SA (NASDAQ:SOPH) Q3 2024 Earnings Call Transcript
Operator: Good morning. My name is Nicole [ph] and I will be your conference operator today.
SOPHiA GENETICS SA (SOPH): A Bull Case Theory
We came across a bullish thesis on SOPHiA GENETICS SA (SOPH) on Two Natural Cap’s Substack by Two Natural Capital. In this article, we will summarize the bulls’ thesis on SOPH.
SOPHiA GENETICS SA (NASDAQ:SOPH) Q2 2024 Earnings Call Transcript
Operator: Good morning. My name is Kevin and I'll be your conference operator for today. At this time, I'd like to welcome everyone to the SOPHiA GENETICS Second Quarter 2024 Earnings Conference Call.
SOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2024 Earnings Call Transcript
Operator: Good day everyone. My name is Jamie and I'll be your conference operator today. At this time, I'd like to welcome everyone to the SOPHiA GENETICS First Quarter 2024 Earnings Conference Call.
5 Fastest Growing Health Tech Companies in the World
In this article, we will be taking a look at the 5 fastest growing health tech companies in the world.
SOPHiA GENETICS SA (NASDAQ:SOPH) Q4 2023 Earnings Call Transcript
SOPHiA GENETICS SA misses on earnings expectations. Reported EPS is $-0.37 EPS, expectations were $-0.25.
SOPHiA GENETICS SA (NASDAQ:SOPH) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree and I will be your conference operator today.
SOPHiA GENETICS SA (NASDAQ:SOPH) Q2 2023 Earnings Call Transcript
Operator: Hello, ladies and gentlemen. And thank you for joining SOPHiA GENETICS Second Quarter 2020 Earnings Call. Our host for today is Katherine Bailon, Head of Investor Relations. Ms.
Billionaire Hedge Funds
